65 results
424B3
QTTB
Q32 Bio Inc.
9 May 24
Prospectus supplement
7:26am
borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines
424B3
QTTB
Q32 Bio Inc.
29 Apr 24
Prospectus supplement
5:10pm
of assets, strategic partnerships or other transactions. Based on the financing environment and the anticipated clinical development timeline for its
8-K
EX-99.5
2rc0sp78
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
424B3
ern4d0idbm8 25
13 Mar 24
Prospectus supplement
1:36pm
424B3
c6plhft
14 Feb 24
Prospectus supplement
4:10pm
S-4/A
so3g8 c1jhp5jbr4wdr
29 Jan 24
Registration of securities issued in business combination transactions (amended)
12:00am
8-K
EX-99.1
v9lzfhganwq96 6p1
26 Jan 24
Regulation FD Disclosure
4:13pm
425
nu3jhtnzu17o4 8eq
26 Jan 24
Business combination disclosure
12:00am
S-4
EX-2.1
vc8hxx2 wzef7yi
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
u2wlbfdsu9a3a5q6vude
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
EX-10.36
x34ixy4skoyo238o
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
425
77l9i3ukj3x
16 Nov 23
Business combination disclosure
4:19pm
425
lxfpao9galg
16 Nov 23
Business combination disclosure
7:46am
8-K
EX-2.1
uaokybh
16 Nov 23
Entry into a Material Definitive Agreement
7:45am